StockData
Stemtech Corp logo

Stemtech Corp (STEK) KPIs and segments

STEKOTCWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 0/30
$0.00+0.00 (0.00%)

Close on Oct 19, 2026Market cap $296.22KP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Stemtech's business

Stemtech's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.

The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.

Add to chartMetric
Q4 2025
Q4 2024
Q4 2023
Q4 2022
Q4 2021
Americas($M)
2.793.143.453.995.21
Latin America($M)
0.340.590.160.200.28
Asia($M)
0.020.050.070.080.22

Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).

Methodology and excluded metrics
  • Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).

Data updated 2026-05-29.

See a number that looks wrong?